BioNexus Gene Lab Corp. (BGLC) Revenue 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$7.4MFY2025 · since FY2018: $212,328 → $7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.4M | -21.9% |
| FY2024 | $9.5M | -2.7% |
| FY2023 | $9.8M | -10.6% |
| FY2022 | $10.9M | -18.2% |
| FY2021 | $13.4M | +17.3% |
| FY2020 | $11.4M | +8872.0% |
| FY2019 | $126,955 | -40.2% |
| FY2018 | $212,328 | — |
Source: SEC XBRL filings · For reference only · Not investment advice